Glycemic Variability Impacted by SGLT2 Inhibitors and GLP 1 Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis

To investigate the effect of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) agonists on glycemic variability (GV), the mean amplitude of glucose excursion (MAGE), mean blood glucose (MBG) levels, and percentage of time maintaining euglycemia were evaluated. Ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Heeyoung, Park, Se-eun, Kim, Eun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470178/
https://www.ncbi.nlm.nih.gov/pubmed/34575189
http://dx.doi.org/10.3390/jcm10184078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470178/
https://www.ncbi.nlm.nih.gov/pubmed/34575189
http://dx.doi.org/10.3390/jcm10184078

Ejemplares similares